Articles From: 2014/1/22 - AMD Offers New Levels of Efficiency With 12- and 16-Core Additions to the AMD Opteron 6300 Series to 2014/1/22 - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG


2014/1/22
http://media.marketwire.com/attachments/201401/TN-217520_Opteron_6300_Series_hand_white_background.jpg AMD today announced 12- and 16-Core additions to the AMD Opteron 6300 Series.
Sign-up for 2014/1/22 - AMD Offers New Levels of Efficiency With 12- and 16-Core Additions to the AMD Opteron 6300 Series investment picks
2014/1/22
Guest Requests Prompt Tim Hortons to Commission Full-length Version of Song in New Sidney Crosby Commercial Canada NewsWire - "Let's Run" available to download for free on Sound Cloud - OAKVILLE, ON , Jan.
Sign-up for 2014/1/22 - Guest Requests Prompt Tim Hortons to Commission Full-length Version of Song in New Sidney Crosby Commercial investment picks
2014/1/22
By Brett Arends Those money managers.
Sign-up for 2014/1/22 - UPDATE: Wall Street is paying too much for stocks investment picks
2014/1/22
Northern Trust Corporation today reported fourth quarter net income per diluted common share of $0.70, up from $0.69 in the fourth quarter of 2012 and down from $0.84 in the third quarter of 2013.
Sign-up for 2014/1/22 - Northern Trust Corporation Reports Fourth Quarter Net Income of $169.7 Million, Earnings Per Common Share of $0.70. investment picks
2014/1/22
Meridian Bioscience, Inc. (NASDAQ: VIVO) today: reported first quarter net sales of $44.8 million, a decrease of 1% from the same period of the prior fiscal year; reported first quarter operating income of $11.6 million, a decrease of 11% from the same period of the prior fiscal year; reported first quarter net earnings of $7.4 million, or $0.18 per diluted share, decreases of 12% and 10%, respectively, compared to the fiscal 2013 first quarter; declared the increased regular quarterly cash dividend of $0.20 per share for the first quarter of fiscal 2014 (indicated rate of $0.80 per share) a 5% increase over the regular quarterly rate for fiscal 2013; and reaffirmed its fiscal 2014 guidance of per share diluted earnings between $0.98 and $1.03 on net sales of
Sign-up for 2014/1/22 - Meridian Bioscience Reports First Quarter 2014 Operating Results, Declares Increased Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance investment picks
2014/1/22
Coach, Inc. (NYSE:COH) (SEHK:6388), a leading New York design house of modern luxury accessories, today announced sales of $1.42 billion for its second fiscal quarter ended December 28, 2013, compared with $1.50 billion reported in the same period of the prior year, a decrease of 6%. On a constant currency basis sales declined 3% for the quarter.
Sign-up for 2014/1/22 - Coach Reports Second Quarter Earnings Per Share of $1.06 investment picks
2014/1/22
The world’s developed nations could reduce their healthcare spending by almost 15 percent by adopting three key reforms according to analysis conducted by the Health & Life Sciences practice of Oliver Wyman released today at the 2014 World Economic Forum Annual Meeting in Davos, Switzerland.
Sign-up for 2014/1/22 - Three Crucial Reforms Could Save the World’s Developed Nations Almost 15 Percent of Their Healthcare Spending investment picks
2014/1/22
CIBC Poll: Confidence Growing as Canadians Take Stock of their 2014 Finances Canada NewsWire While confidence in reaching financial goals is on the rise, Canadians' view of their current finances has remained the same over a 4 year period TORONTO , Jan.
Sign-up for 2014/1/22 - CIBC Poll: Confidence Growing as Canadians Take Stock of their 2014 Finances investment picks
2014/1/22
KYOTO, Japan, Jan.
Sign-up for 2014/1/22 - Nidec Board Authorizes Share Repurchases investment picks
2014/1/22
As Part of AT&T's Project VIP Investment, Customers to Benefit From Nation's Most Reliable 4G LTE Network on the Latest Devices LA CROSSE, Wis.
Sign-up for 2014/1/22 - AT&T 4G LTE Available In La Crosse investment picks
2014/1/22
Penn West to present at CIBC Whistler Institutional Investor Conference Canada NewsWire We invite interested parties to visit: https://webcasts.welcome2theshow.com/whistler2014 at the presentation time noted above to listen to an audio webcast of the presentation.
Sign-up for 2014/1/22 - Penn West to present at CIBC Whistler Institutional Investor Conference investment picks
2014/1/22
DALLAS/FORT WORTH, Texas , Jan.
Sign-up for 2014/1/22 - Texas Online Schools Plan Events to Mark National School Choice Week (Jan. 25-Feb. 1) investment picks
2014/1/22
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Tech stocks are expected to dominate headlines in after-hours trading on Wednesday, with Netflix Inc., eBay Inc., and SanDisk Corp.
Sign-up for 2014/1/22 - Netflix, eBay, SanDisk results to dominate after hours investment picks
2014/1/22
ADVISORY, Jan.
Sign-up for 2014/1/22 - Intercept Pharmaceuticals, Inc. [ICPT] to Ring The NASDAQ Stock Market Closing Bell investment picks
2014/1/22
PeopleNet and TMW Systems Partner with NTTC to Strengthen Advocacy Efforts ARLINGTON, Va.
Sign-up for 2014/1/22 - NTTC Announces Exclusive Sponsorship of NTTC PAC Events investment picks
2014/1/22
' Best British TV' Streaming Service Triples Subscribers and Grows 475% in Weekly Views SILVER SPRING, Md., Jan.
Sign-up for 2014/1/22 - Acorn TV's Record-Breaking Year With Exclusive North American Premieres of Hit British Mysteries and Dramas investment picks
2014/1/22
VERNON HILLS, Ill., Jan.
Sign-up for 2014/1/22 - CDW Corporation Announces Partial Redemption of Senior Subordinated Exchange Notes Due 2017 investment picks
2014/1/22
Deals Total 63 Hours of Finished Tape for Shows Including The Hero, 72 Hours and Duck Commander LOS ANGELES , Jan.
Sign-up for 2014/1/22 - Electus International Signs Multiple Deals With SPT Networks Russia for Distribution to the Commonwealth of Independent States and The Baltic States investment picks
2014/1/22
SOUTHBOROUGH, Mass., Jan.
Sign-up for 2014/1/22 - Sevcon to Announce First-Quarter 2014 Financial Results on February 4 investment picks
2014/1/22
http://media.marketwire.com/attachments/201306/161275_Trunity20Logo201092x280MAC_optimized_tif.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1083551&ProfileId=051205&sourceType=1 PORTSMOUTH, NH --
Sign-up for 2014/1/22 - Trunity Holdings to Participate in the FETC 2014 National Conference investment picks
2014/1/22
- Data Demonstrate Preliminary Evidence of Anti-Tumor Activity of Oral Selinexor in Colorectal Cancer Patients - - Potential Anti-Proliferative Activity of Novel PAK4 Inhibitor Seen in Preclinical Pancreatic Cancer Model - NATICK, Mass., Jan.
Sign-up for 2014/1/22 - Karyopharm Therapeutics Presents Clinical Data on Selinexor (KPT-330) in Colorectal Cancer From Ongoing Phase 1 Study and Preclinical Data on Novel PAK4 Inhibitors at American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium investment picks
2014/1/22
W. Keith Kennedy, Jr.
Sign-up for 2014/1/22 - Con-way Inc. Board of Directors Announces Transition in Board Leadership investment picks
2014/1/22
By Amol Sharma and Shalini Ramachandran Amazon.com Inc. has approached big entertainment companies about licensing their television channels for a new online pay-TV service it is considering launching, in what would mark a significant expansion of the company's online video efforts.
Sign-up for 2014/1/22 - UPDATE: Amazon considering online pay-TV service investment picks
2014/1/22
Biocon Ltd., (BIOCON.BO), Asia’s premier biotechnology company, and Advaxis, Inc ., (NASDAQ: ADXS), a leader in developing the next generation of cancer immunotherapies, announced today that they have entered into an exclusive licensing agreement for co-development and commercialization of ADXS-HPV , a novel cancer immunotherapy for the treatment of human papillomavirus (HPV)-associated cervical cancer in women, for India and key emerging markets.
Sign-up for 2014/1/22 - Biocon Collaborates with Advaxis for ‘ADXS-HPV’ A Novel Cancer Immunotherapy investment picks
2014/1/22
By Sue Chang and Saumya Vaishampayan, MarketWatch SAN FRANCISCO (MarketWatch) -- Shares of Apple Inc. got a jolt on Wednesday after billionaire Carl Icahn used Twitter to step up his long-running criticism of the company's board and again push for a bigger share buyback.
Sign-up for 2014/1/22 - UPDATE: Apple up as Carl Icahn lashes out at board via Twitter investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/1/22 - AMD Offers New Levels of Efficiency With 12- and 16-Core Additions to the AMD Opteron 6300 Series to 2014/1/22 - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity